Brian Grass bought $215k of HELE
Chief Executive Officer at HELEN OF TROY LTD. 10,000 shares at an average of $21.47, traded Jul 15, 2025, filed Jul 15, 2025.
Score components
- +25RoleCEO
- +12Trade size$215k at market
- +3Relative to holdingsHoldings up 8%
- 0Price contextNo price history yet
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +17.6%, 3m +3.4%, 6m -6.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000916789-25-000044, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 15, 2025 | POpen-market purchase Common Shares, Par value $0.10 per share | +10,000 | $21.47 | $215k | 135,932 | Jul 15, 2025 |
Related signals
Other insiders at HELEN OF TROY LTD and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | HELEN OF TROY LTD | Tessa Judge Chief Legal Officer | $9,948 435 shares | +2% | |
| 55Moderate | HELEN OF TROY LTD | Tracy Scheuerman Chief Financial Officer | $201k 10,000 shares | +43% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.